Ironwood Pharmaceuticals Quote - IRWD

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.69

Bid

3.44

Offer

3.95

Volume

1,928,791

3.39 Day's Range 3.7475

3.06 52 Week Range 15.70

Market Cap

590.505M

Previous Close

3.72

Open

3.72

Last Trade

573072

3.69

(priorref)

Last Trade Time

Financial Volume

US$ 6,892,856

VWAP

3.5737

Average Volume (3m)

1,560,765

Shares Outstanding

160,028,388

Dividend Yield

PE Ratio

-0.59

Earnings Per Share (EPS)

-6.26

Revenue

442.74M

Net Profit

-1B

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic const... Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ironwoodpharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Ironwood Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IRWD. The last closing price for Ironwood Pharmaceuticals was US$3.72. Over the last year, Ironwood Pharmaceuticals shares have traded in a share price range of US$ 3.06 to US$ 15.70.

Ironwood Pharmaceuticals currently has 160,028,388 shares in issue. The market capitalisation of Ironwood Pharmaceuticals is US$595.31 million. Ironwood Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.59.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.15	4.23728813559	3.54	4.05	3.06	2039798	3.63367199	CS
4	-0.66	-15.1724137931	4.35	4.475	3.06	1742972	3.64457315	CS
12	-0.79	-17.6339285714	4.48	5.07	3.06	1560765	4.05367479	CS
26	-2.79	-43.0555555556	6.48	7.105	3.06	1900211	4.93091136	CS
52	-6.74	-64.6212847555	10.43	15.7	3.06	2801405	8.30675826	CS
156	-7.32	-66.485013624	11.01	15.7	3.06	2526706	9.95840106	CS
260	-8.77	-70.3852327448	12.46	15.7	3.06	2283515	10.38267273	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LAESSEALSQ Corporation	US$ 1.1406 (99.75%)	225.46M
AMPGAmplitech Group Inc	US$ 1.9001 (91.52%)	201.88M
CADLCandel Therapeutics Inc	US$ 7.7401 (67.90%)	100.61M
JZXNJiuzi Holdings Inc	US$ 1.792 (60.00%)	2.56M
LDTCLeddarTech Holdings Inc	US$ 1.81 (49.59%)	75.14M
SFHGSamfine Creation Holdings Group Ltd	US$ 3.04 (-85.59%)	10.2M
CLRBCellectar Biosciences Inc	US$ 0.3039 (-76.26%)	37.51M
QTTBQ32 Bio Inc	US$ 6.0291 (-75.30%)	3.39M
TFFPTFF Pharmaceuticals Inc	US$ 0.1639 (-45.78%)	3.5M
MARXMars Acquisition Corporation	US$ 7.24 (-33.33%)	54.57k
RGTIRigetti Computing Inc	US$ 7.38 (13.71%)	307.29M
LAESSEALSQ Corporation	US$ 1.1406 (99.75%)	223.51M
AMPGAmplitech Group Inc	US$ 1.9001 (91.52%)	200.45M
NVDANVIDIA Corporation	US$ 139.31 (3.14%)	182.44M
LCIDLucid Group Inc	US$ 2.44 (3.39%)	110.58M